This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sumiyoshi, H. Articles by Wargovich, M. J. Search for Related Content PubMed PubMed Citation Articles by Sumiyoshi, H. Articles by Wargovich, M. J.

Heterogenicity of Ornithine Decarboxylase during Mouse Colon Carcinogenesis and in Human Colon Tumors¹

Section of Gastrointestinal Oncology and Digestive Diseases, Department of Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030

Ornithine decarboxylase (ODC) was separated, using diethylaminoethyl ion-exchange chromatography, into multiple peaks of activity. We investigated the isoforms of ODC during 1,2-dimethylhydrazine-induced colon carcinogenesis and in human colon tumors. ODC in both mouse and human normal-appearing colonic mucosa was consistently separated into two active peaks by diethylaminoethyl-Sepharose CL-6B column chromatography. The major peak (Peak I) contained about 75% of the mouse and 72% of the human colonic mucosal ODC activity. During and after 10 weekly injections of 1,2-dimethylhydrazine (20 mg/kg, i.p.), colonic ODC activity was significantly enhanced with induction of both peaks but with a more significant increase in Peak II. ODC activity in both 1,2-dimethylhydrazine-induced and human colon tumors was significantly higher compared with the normal colon mucosa. The chromatographic profile of tumors showed the predominance of the second peak. Furthermore, the chromatographic profile of ODC after alkaline phosphatase treatment yielded an elution of only one peak coincident with the Peak I and the disappearance of Peak II. The second peak of ODC (the phosphorylated form) may be a specific isoform associated with colon tumorigenesis and tumor growth.

¹ Supported by a grant from the Wakunaga Pharmaceutical Co., Osaka, Japan.

² To whom requests for reprints should be addressed, at Section of Gastrointestinal Oncology and Digestive Diseases, Box 78, University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030.

Received 7/23/90. Accepted 2/ 4/91.

This article has been cited by other articles:

				S. G. Reddy, S. M. Mcllheran, B. J. Cochran, L. L. Worth, L. A. Bishop, P. J. Brown, V. P. Knutson, and M. K. Haddox Multisite Phosphorylation of Ornithine Decarboxylase in Transformed Macrophages Results in Increased Intracellular Enzyme Stability and Catalytic Efficiency J. Biol. Chem., October 4, 1996; 271(40): 24945 - 24953. [Abstract] [Full Text] [PDF]